NO177714C - Analogifremgangsmåte for fremstilling av terapeutisk aktive peptidderivater - Google Patents

Analogifremgangsmåte for fremstilling av terapeutisk aktive peptidderivater

Info

Publication number
NO177714C
NO177714C NO891389A NO891389A NO177714C NO 177714 C NO177714 C NO 177714C NO 891389 A NO891389 A NO 891389A NO 891389 A NO891389 A NO 891389A NO 177714 C NO177714 C NO 177714C
Authority
NO
Norway
Prior art keywords
therapeutically active
active peptide
peptide derivatives
analogous process
preparing therapeutically
Prior art date
Application number
NO891389A
Other languages
English (en)
Norwegian (no)
Other versions
NO177714B (no
NO891389D0 (no
NO891389L (no
Inventor
Tohru Kino
Motoaki Nishikawa
Masami Ezaki
Sumio Kiyoto
Masakuni Okuhara
Shigehiro Takase
Satoshi Okada
Nobuharu Shigematsu
Original Assignee
Fujisawa Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fujisawa Pharmaceutical Co filed Critical Fujisawa Pharmaceutical Co
Publication of NO891389D0 publication Critical patent/NO891389D0/no
Publication of NO891389L publication Critical patent/NO891389L/no
Publication of NO177714B publication Critical patent/NO177714B/no
Publication of NO177714C publication Critical patent/NO177714C/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04Linear peptides containing only normal peptide links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04Linear peptides containing only normal peptide links
    • C07K7/06Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/08Bronchodilators
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20Bacteria; Culture media therefor
    • C12N1/205Bacterial isolates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12RINDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00Microorganisms ; Processes using microorganisms
    • C12R2001/01Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/465Streptomyces

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pulmonology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Engineering & Computer Science (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Investigating Or Analyzing Materials By The Use Of Ultrasonic Waves (AREA)
  • Ultra Sonic Daignosis Equipment (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NO891389A 1988-04-05 1989-04-03 Analogifremgangsmåte for fremstilling av terapeutisk aktive peptidderivater NO177714C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB888807921A GB8807921D0 (en) 1988-04-05 1988-04-05 Ws-9326 & its derivatives

Publications (4)

Publication Number Publication Date
NO891389D0 NO891389D0 (no) 1989-04-03
NO891389L NO891389L (no) 1989-10-06
NO177714B NO177714B (no) 1995-07-31
NO177714C true NO177714C (no) 1995-11-08

Family

ID=10634574

Family Applications (1)

Application Number Title Priority Date Filing Date
NO891389A NO177714C (no) 1988-04-05 1989-04-03 Analogifremgangsmåte for fremstilling av terapeutisk aktive peptidderivater

Country Status (20)

Country Link
EP (1) EP0336230B1 (uk)
JP (1) JP2551142B2 (uk)
KR (1) KR0132567B1 (uk)
CN (1) CN1037857C (uk)
AT (1) ATE148890T1 (uk)
AU (1) AU627453B2 (uk)
CA (1) CA1335662C (uk)
DE (1) DE68927759T2 (uk)
DK (1) DK161789A (uk)
ES (1) ES2097736T3 (uk)
FI (1) FI102547B1 (uk)
GB (1) GB8807921D0 (uk)
GR (1) GR3023353T3 (uk)
HU (1) HU204853B (uk)
IL (1) IL89734A (uk)
NO (1) NO177714C (uk)
PH (1) PH30960A (uk)
RU (2) RU1826970C (uk)
UA (1) UA26845C2 (uk)
ZA (1) ZA892188B (uk)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0360390A1 (en) * 1988-07-25 1990-03-28 Glaxo Group Limited Spirolactam derivatives
US5093127A (en) * 1989-06-02 1992-03-03 Fujisawa Pharmaceutical Co., Ltd. Preparation of fr115224 substrate for parenteral administration
FR2666335B1 (fr) 1990-09-05 1992-12-11 Sanofi Sa Arylalkylamines, procede pour leur preparation et compositions pharmaceutiques les contenant.
EP0498069B1 (en) * 1990-12-21 1995-10-25 Fujisawa Pharmaceutical Co., Ltd. New use of peptide derivative
FR2688219B1 (fr) 1992-03-03 1994-07-08 Sanofi Elf Sels d'ammonium quaternaires de composes aromatiques amines, leur preparation et compositions pharmaceutiques les contenant.
US5830854A (en) * 1992-12-14 1998-11-03 Merck Sharp & Dohme, Limited Method of treating cystic fibrosis using a tachykinin receptor antagonist
WO1994020126A1 (en) * 1993-03-03 1994-09-15 Fujisawa Pharmaceutical Co., Ltd. Use of peptides for the manufacture of a medicament
FR2728166A1 (fr) 1994-12-19 1996-06-21 Oreal Composition topique contenant un antagoniste de substance p
FR2728169A1 (fr) 1994-12-19 1996-06-21 Oreal Utilisation d'un antagoniste de substance p pour le traitement des prurits et des dysesthesies oculaires ou palpebrales
FR2728165A1 (fr) 1994-12-19 1996-06-21 Oreal Utilisation d'un antagoniste de substance p pour le traitement des rougeurs cutanees d'origine neurogene
FR2729954B1 (fr) 1995-01-30 1997-08-01 Sanofi Sa Composes heterocycliques substitues, procede pour leur preparation et compositions pharmaceutiques les contenant
FR2741262B1 (fr) 1995-11-20 1999-03-05 Oreal Utilisation d'un antagoniste de tnf-alpha pour le traitement des rougeurs cutanees d'origine neurogene
BRPI0807972A2 (pt) 2007-01-24 2014-06-10 Glaxo Group Ltd Composições farmacêuticas compreendendo 3,5-diamino-6-(2,3-diclofenil)-l,2,4-triazina ou r(-)-2,4-diamino-5-(2,3-diclorofenil)-6-fluorometilpirim idina e uma nk1
UA105182C2 (uk) 2008-07-03 2014-04-25 Ньюрексон, Інк. Бензоксазини, бензотіазини і споріднені сполуки, що мають інгібуючу nos активність

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4661473A (en) * 1984-03-27 1987-04-28 Merck & Co., Inc. Renin inhibitors containing peptide isosteres
US4803261A (en) * 1986-06-27 1989-02-07 The Administrators Of The Tulane Educational Fund Method for synthesizing a peptide containing a non-peptide
JPS6424156A (en) * 1987-07-17 1989-01-26 Yanmar Diesel Engine Co Air-fuel ratio control device for gas engine
JP2570670B2 (ja) * 1987-12-28 1997-01-08 味の素株式会社 トキソプラズマ増殖抑制剤
GB8802229D0 (en) * 1988-02-02 1988-03-02 Fujisawa Pharmaceutical Co Ws-9326 & its derivatives

Also Published As

Publication number Publication date
DK161789D0 (da) 1989-04-04
UA26845C2 (uk) 1999-12-29
DE68927759T2 (de) 1997-06-19
EP0336230A3 (en) 1991-07-17
JPH02204499A (ja) 1990-08-14
CN1036795A (zh) 1989-11-01
NO177714B (no) 1995-07-31
JP2551142B2 (ja) 1996-11-06
NO891389D0 (no) 1989-04-03
GR3023353T3 (en) 1997-08-29
KR890016061A (ko) 1989-11-28
DE68927759D1 (de) 1997-03-27
HU204853B (en) 1992-02-28
HUT49631A (en) 1989-10-30
RU1826970C (ru) 1993-07-07
KR0132567B1 (ko) 1998-04-14
ES2097736T3 (es) 1997-04-16
RU2043365C1 (ru) 1995-09-10
IL89734A0 (en) 1989-09-28
FI891581A (fi) 1989-10-06
IL89734A (en) 1994-05-30
FI102547B (fi) 1998-12-31
EP0336230A2 (en) 1989-10-11
PH30960A (en) 1997-12-23
ATE148890T1 (de) 1997-02-15
ZA892188B (en) 1989-11-29
AU3239789A (en) 1989-10-12
FI891581A0 (fi) 1989-04-03
AU627453B2 (en) 1992-08-27
NO891389L (no) 1989-10-06
FI102547B1 (fi) 1998-12-31
EP0336230B1 (en) 1997-02-12
DK161789A (da) 1989-10-06
CN1037857C (zh) 1998-03-25
GB8807921D0 (en) 1988-05-05
CA1335662C (en) 1995-05-23

Similar Documents

Publication Publication Date Title
NO904904L (no) Fremgangsmaate for fremstilling av en polypeptidforbindelse
AU3829089A (en) Fr901228 substance and preparation thereof
HUT53368A (en) Process for producing pyrazolo-pyridine derivatives and pharmaceutical compositions containing them
HUT58735A (en) Process for producing pyrazolo-pyridine derivatives
NO177714C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive peptidderivater
HU901427D0 (en) Process for the preparation of ws7622 a, b, c and d
AU640241B2 (en) Ws7622a mono- or di-sulfate, process for preparation thereof and use thereof
NO174886C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive pyrrolidin-derivater
NO174963C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive 8-fluorantracyklinglucosider
HUT59936A (en) Process for producing 10,11,12,13-tetrahydro-demicosin derivatives and pharmaceutical compositions containing them as active components

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees

Free format text: LAPSED IN OCTOBER 2001